U.S., Feb. 1 -- ClinicalTrials.gov registry received information related to the study (NCT06802666) titled 'Short-course Radiotherapy Followed by AK112 and CAPOX as Neoadjuvant Therapy for Locally Advanced Rectal Cancer' on Jan. 18.
Brief Summary: This study aims to evaluate the efficacy and safety of short-course radiotherapy followed by AK112 in combination with CAPOX as neoadjuvant therapy in patients with locally advanced rectal cancer
Study Start Date: Oct. 16, 2024
Study Type: INTERVENTIONAL
Condition:
Locally Advanced Rectal Cancer
Neoadjuvant Therapy
Intervention:
RADIATION: short-course radiotherapy
Eligible subjects will receive short-course radiotherapy (SCRT). One week after the end of treatment, subjects continued to re...